medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2010, Number 1

<< Back Next >>

Rev Mex Oftalmol 2010; 84 (1)

Hipertensión ocular postqueratoplastía

Rojas-Alvarez E, Méndez-Duque EAM, González-Sotero J, Casanueva-Cabeza HC, Alberro-Hernández M

Language: Spanish
References: 26
Page: 30-33
PDF size: 72.76 Kb.


ABSTRACT

We performed an exploratory study with the aim of presenting the main aspects related to the diagnosis and treatment of postkeratoplasty ocular hypertension. We performed a literature search of key articles of the past 10 years related to the topic, as well as printed literature that includes the subject. The most relevant content was selected for the preparation of the final report. It was found that ocular hypertension occurs more commonly after penetrating keratoplasty and a compromised graft. Appropriate measures before, during and after surgery help reduce intraocular pressure, it is necessary to recognize the early rise in IOP and indicate the appropriate treatment; specialists in cornea and glaucoma must work together to identify and meet the medical and surgical decision in view of the behavior of refractory glaucoma, that required trabeculectomy combined with pharmacological therapy with antimetabolites. Other surgical procedures include use of drainage and trans-scleral cyclophotocoagulation.


REFERENCES

  1. Kaufman HE. Strengthening the cornea. Cornea 2004; 23:432.

  2. Thompson P, Price R. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol 2003; 121(8): 1087-1092.

  3. Foulks G. Glaucoma associated with penetrating keratoplasty. Ophthalmol 1987; 94(7):871-874.

  4. Oliva MS, Taylor H. Complicaciones inminentes en los trasplantes de córnea: diagnóstico y manejo parte 1. Highlights of Ophthalmology 2004; 32(4):2-6.

  5. Kaminska A, Szaflik J. Retrospective evaluation of risk factors for graft rejection in patients after corneal transplantation performed at the Eye Clinic in the years 2001-2003. Klinika Oczna 2005; 107:209-211.

  6. Trigui A. Corneal graft rejection: donor and receiver implication. J Fr Opthalmol 2005; 28:631-634.

  7. Terry MA, Ousley PJ. Deep lamellar endothelial keratoplasty visual acuity, astigmatism, and endothelial survival in a large prospective series. Ophthalmology 2005; 112:1541-1548.

  8. Fogla R, Padmanabhan P. Initial results of small incision deep lamellar endothelial keratoplasty (DLEK). Am J Ophthalmol 2006; 141:346-351.

  9. Williams KA, Esterman AJ. How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 2006; 81:896-901.

  10. Kenney MC, Brown DJ. The cascade hypothesis of keratoconus. Contact Lens & Anterior Eye 2003; 26:139-146.

  11. Lindquist TD, Mcneill JI. Indications for keratoplasty. Cornea 1994; 13:105-107.

  12. Aardjomand N, Komericki P. ABO blood group expression in corneal allograft failures. Ophthalmology 2005; 102:981-986.

  13. Dua HS, Azuara-Blanco A. Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment. Indian J Ophthalmol 1999; 47:3-9.

  14. Hawa-Montiel H. Trasplante de córnea. Criterio clínico quirúrgico. Rev Invest Clin 2005; 57 (2):358-367

  15. Fasolo A, The CORTES Study: Corneal Transplant Indications and Graft Survival in an Italian Cohort of Patients. Cornea 2006; 25:507-515.

  16. Thompson R, Price M, Bowers P. Long term graft survival after penetrating keratoplasty. Ophthalmol 2003; 110(7):1396- 1402.

  17. Koay PY, Lee WH, Figueiredo FC. Opinions on risk factors and management of corneal graft rejection in the United Kingdom. Cornea 2005; 24:292-296.

  18. Niederkorn JY. Ocular Immune privilege: Nature’s strategy for preserving vision. Science and Medicine 2003; 9:320-333.

  19. Inoue K. Risk factors for corneal graft failure and rejection in penetrating keratoplasty. Acta Ophthalmol Scand 2001; 79:251-255.

  20. Arentsen JJ. Corneal transplant allograft reaction: possible predisposing factors. Trans Am Ophthalmol Soc 1983; 81:361-402.

  21. Fink N. Effectiveness of histocompatibility matching in highrisk corneal transplantation: a summary of results from the Collaborative Corneal Transplantation Studies. Cesk Oftalmol 1994; 50(1):3-12.

  22. Rumelt S. Systemic cyclosporine. A high failure risk, repeated corneal transplantation. Br J Ophthalmology 2002; 8(9):9.

  23. Xic L. Prolongation of corneal allograft survival using cyclosporine in a polylacticde-coglycolide polymer. Cornea 2001; 20(7):752.

  24. Sherwood MB. Drainaje tube implants in the treatment of glaucoma following penetrating queratoplasty. Ophthalmic Surg 1993; 24:185-189.

  25. Tomey KF, Traverso CE. The glaucomas in aphakia and pseudophaquia. Surv Ophthalmol 1991; 36:79-112.

  26. Walsh JB, Muldoon TO. Glaucoma associated with retinal and vitreoretinal disorders. St Louis: Mosby, 1996; 50:1055- 1071.




2020     |     www.medigraphic.com